Bank of New York Mellon’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-59,791
| Closed | -$99K | – | 4781 |
|
|
2022
Q1 | $99K | Sell |
59,791
-787
| -1% | -$1.3K | ﹤0.01% | 4404 |
|
|
2021
Q4 | $145K | Sell |
60,578
-18,736
| -24% | -$44.8K | ﹤0.01% | 4346 |
|
|
2021
Q3 | $433K | Buy |
79,314
+28,786
| +57% | +$157K | ﹤0.01% | 3884 |
|
|
2021
Q2 | $376K | Buy |
50,528
+5,069
| +11% | +$37.7K | ﹤0.01% | 3897 |
|
|
2021
Q1 | $368K | Buy |
45,459
+7,586
| +20% | +$61.4K | ﹤0.01% | 3832 |
|
|
2020
Q4 | $344K | Buy |
37,873
+6,156
| +19% | +$55.9K | ﹤0.01% | 3774 |
|
|
2020
Q3 | $351K | Sell |
31,717
-1,960
| -6% | -$21.7K | ﹤0.01% | 3651 |
|
|
2020
Q2 | $250K | Sell |
33,677
-1,042
| -3% | -$7.74K | ﹤0.01% | 3739 |
|
|
2020
Q1 | $214K | Buy |
34,719
+3,744
| +12% | +$23.1K | ﹤0.01% | 3722 |
|
|
2019
Q4 | $155K | Buy |
30,975
+13,729
| +80% | +$68.7K | ﹤0.01% | 3959 |
|
|
2019
Q3 | $130K | Buy |
+17,246
| New | +$130K | ﹤0.01% | 3975 |
|